Arrowhead Pharmaceuticals Inc

Arrowhead Pharmaceuticals Inc Stock

48.50P/E
€5.62BMarket capitalisation
-US$5.11Earnings
—Dividend yield

Key metrics

Key metrics and master data for the Arrowhead Pharmaceuticals Inc stock.

Company size
Market capitalisation
€5.62B
Market value
€5.45B
Enterprise value
€6.49B
Key metrics
P/E
48.50
P/B
16.79
P/S
13.68
P/CF
-280.30
PEG Ratio
—
Return on Investment (ROI)
-280.50 %
Revenue and cash flow
Revenue
€239.22M
EBITDA
-€603.59M
EBIT
-€630.21M
Free cash flow
-€283.94M
Number of stocks
Issued shares141M Units
Number of shares in free float102M Units

Forecasts

Here you can find forecasts for the Arrowhead Pharmaceuticals Inc stock.

Estimated earnings per share
-US$2.86
Estimated dividend yield —
Estimated earnings yield-5.95 %
Estimated P/E ratio -13.69

Would you like to use this feature and unlock the full potential of your investments?

Register now on extraETF.com and get unlimited access to all data & features.
Create portfolios, watchlists and price alerts, and use our professional-grade investment analysis.

Sign up now

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.